ADMA Biologics Inc
ADMA14.710USD
+0.190+1.31%
收盤 11/10, 16:00（美東）報價延遲15分鐘
3.51B總市值
16.74本益比TTM
關於 ADMA Biologics Inc 公司
ADMA Biologics, Inc. 是一家端到端商業生物製藥公司，致力於製造、營銷和開發用於治療有感染風險的免疫缺陷患者和其他有某些傳染病風險的患者的特種生物製劑。該公司製造和營銷三種經美國食品藥品管理局 (FDA) 批准的血漿衍生生物製劑，用於治療免疫缺陷和預防某些傳染病：BIVIGAM（人靜脈注射免疫球蛋白），用於治療原發性體液免疫缺陷 (PI)；ASCENIV（人靜脈注射免疫球蛋白 - slra 10% 液體），用於治療 PI；NABI-HB（人乙肝免疫球蛋白），用於增強對乙肝病毒的免疫力。通過其子公司 ADMA BioCenters，該公司還在美國經營 FDA 批准的血漿採集者，爲其產品製造提供血漿。
ADMA Biologics Inc簡介
公司代碼ADMA
公司名稱ADMA Biologics Inc
上市日期Oct 17, 2013
CEOMr. Adam S. Grossman
員工數量677
證券類型Ordinary Share
年結日Oct 17
公司地址465 State Route 17
城市RAMSEY
上市交易所NASDAQ Global Market Consolidated
國家United States of America
郵編07446
電話12014785552
網址https://www.admabiologics.com/
公司代碼ADMA
上市日期Oct 17, 2013
CEOMr. Adam S. Grossman
ADMA Biologics Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Adam S. Grossman
Mr. Adam S. Grossman
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
3.74M
-0.16%
Dr. Jerrold B. Grossman
Dr. Jerrold B. Grossman
Vice Chairman of the Board, Co-Founder
Vice Chairman of the Board, Co-Founder
570.90K
--
Mr. Brad L. Tade
Mr. Brad L. Tade
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
258.17K
-2.68%
Mr. Lawrence P. Guiheen
Mr. Lawrence P. Guiheen
Independent Director
Independent Director
145.83K
-12.06%
Mr. Steven A. (Steve) Elms
Mr. Steven A. (Steve) Elms
Independent Chairman of the Board
Independent Chairman of the Board
87.33K
--
Mr. Eduardo Rene Salas
Mr. Eduardo Rene Salas
Independent Director
Independent Director
10.89K
--
Dr. Young T. Kwon, Ph.D.
Dr. Young T. Kwon, Ph.D.
Independent Director
Independent Director
--
--
Ms. Alison C. Finger
Ms. Alison C. Finger
Independent Director
Independent Director
--
--
Ms. Kaitlin Kestenberg
Ms. Kaitlin Kestenberg
Chief Operating Officer, Senior Vice President - Compliance
Chief Operating Officer, Senior Vice President - Compliance
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Adam S. Grossman
Mr. Adam S. Grossman
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
3.74M
-0.16%
Dr. Jerrold B. Grossman
Dr. Jerrold B. Grossman
Vice Chairman of the Board, Co-Founder
Vice Chairman of the Board, Co-Founder
570.90K
--
Mr. Brad L. Tade
Mr. Brad L. Tade
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
258.17K
-2.68%
Mr. Lawrence P. Guiheen
Mr. Lawrence P. Guiheen
Independent Director
Independent Director
145.83K
-12.06%
Mr. Steven A. (Steve) Elms
Mr. Steven A. (Steve) Elms
Independent Chairman of the Board
Independent Chairman of the Board
87.33K
--
Mr. Eduardo Rene Salas
Mr. Eduardo Rene Salas
Independent Director
Independent Director
10.89K
--
收入明細
單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
暫無數據
地區USD
名稱
營收
佔比
United States
121.98M
0.00%
International
0.00
0.00%
業務
地區
暫無數據
股東統計
更新時間: 10月24日 週五
更新時間: 10月24日 週五
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
14.01%
The Vanguard Group, Inc.
8.79%
State Street Investment Management (US)
5.08%
Invesco Advisers, Inc.
4.28%
Geode Capital Management, L.L.C.
2.48%
其他
65.35%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
14.01%
The Vanguard Group, Inc.
8.79%
State Street Investment Management (US)
5.08%
Invesco Advisers, Inc.
4.28%
Geode Capital Management, L.L.C.
2.48%
其他
65.35%
股東類型
持股股東
佔比
Investment Advisor
50.09%
Investment Advisor/Hedge Fund
29.08%
Hedge Fund
5.68%
Individual Investor
2.56%
Research Firm
2.01%
Private Equity
1.44%
Pension Fund
1.21%
Bank and Trust
0.44%
Venture Capital
0.24%
其他
7.26%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
724
215.13M
90.39%
-25.52M
2025Q2
680
225.21M
94.37%
-6.16M
2025Q1
658
218.51M
91.53%
-12.93M
2024Q4
607
216.39M
91.46%
-18.31M
2024Q3
547
221.08M
93.58%
+11.33M
2024Q2
451
193.54M
83.08%
-7.68M
2024Q1
408
187.57M
81.05%
-5.26M
2023Q4
371
181.77M
80.46%
-8.48M
2023Q3
362
185.07M
81.97%
+86.17K
2023Q2
349
179.85M
80.15%
-7.63M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
33.35M
13.98%
-846.07K
-2.47%
Jun 30, 2025
The Vanguard Group, Inc.
21.31M
8.93%
+4.52M
+26.94%
Jun 30, 2025
State Street Investment Management (US)
12.08M
5.06%
+637.73K
+5.57%
Jun 30, 2025
Invesco Advisers, Inc.
10.20M
4.27%
+508.12K
+5.24%
Jun 30, 2025
Geode Capital Management, L.L.C.
5.91M
2.48%
+245.31K
+4.33%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
4.76M
2%
-97.24K
-2.00%
Jun 30, 2025
American Century Investment Management, Inc.
4.61M
1.93%
+358.63K
+8.43%
Jun 30, 2025
Thrivent Asset Management, LLC
3.32M
1.39%
+1.45M
+78.10%
Jun 30, 2025
Nuveen LLC
4.10M
1.72%
+638.57K
+18.45%
Jun 30, 2025
Grossman (Adam S)
3.75M
1.57%
-6.00K
-0.16%
Sep 15, 2025
查看更多
持股ETF
更新時間: 11月6日 週四
更新時間: 11月6日 週四
機構名稱
佔比
Invesco S&P SmallCap Health Care ETF
2.22%
SPDR S&P Biotech ETF
1.34%
Harbor Health Care ETF
1.17%
Virtus LifeSci Biotech Products ETF
1.13%
AAM Sawgrass US Small Cap Quality Growth ETF
1.12%
Invesco S&P SmallCap Quality ETF
1.1%
Invesco S&P SmallCap 600 Pure Growth ETF
0.98%
Invesco S&P SmallCap 600 GARP ETF
0.98%
Invesco S&P SmallCap Momentum ETF
0.73%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.73%
查看更多
Invesco S&P SmallCap Health Care ETF
佔比2.22%
SPDR S&P Biotech ETF
佔比1.34%
Harbor Health Care ETF
佔比1.17%
Virtus LifeSci Biotech Products ETF
佔比1.13%
AAM Sawgrass US Small Cap Quality Growth ETF
佔比1.12%
Invesco S&P SmallCap Quality ETF
佔比1.1%
Invesco S&P SmallCap 600 Pure Growth ETF
佔比0.98%
Invesco S&P SmallCap 600 GARP ETF
佔比0.98%
Invesco S&P SmallCap Momentum ETF
佔比0.73%
Pacer US Small Cap Cash Cows Growth Leaders ETF
佔比0.73%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
